IL17A and Arthritis: A preventive treatment with the anti-IL-17 antibodies (starting from the day of the immunization), almost completely abrogated arthritis development in IFN-γR KO mice and inhibited the influx of immunocompetent cells (predominantly neutrophils), hyperplasia of the synovial membrane and bone destruction.